Skip to main content
. 2023 Dec 18;6(1):fcad346. doi: 10.1093/braincomms/fcad346

Figure 1.

Figure 1

Study design. This graphical representation showcases the two-stage study design. Stage 1 consisted of a prescription drug evaluation using LBD cases and controls sampled from the US Medicare database. In Stage 2, we studied the polygenic overlap between cardiovascular disease traits and LBD using genomic data.